Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 5:55 PM
Ignite Modification Date: 2025-12-24 @ 5:55 PM
NCT ID: NCT05135468
Eligibility Criteria: Inclusion Criteria: 1. Having voluntarily signed the ICF approved by the Ethics Committee and consented to participate in this study before starting any study procedure; 2. Being able to understand and comply with the requirements of the protocol and agreeing to participate in all study visits; 3. Males aged 18 to 41 years (inclusive); 4. Being diagnosed with Type III vertex, Type IV or Type V androgenetic alopecia (AGA) according to the Hamilton-Norwood classification (see Appendix 1 for details); 5. Appropriate medical contraceptive methods being used to prevent the sexual partner from becoming pregnant from the time of signing ICF to 28 days after the last dose; - Exclusion Criteria: 1. A history of scalp skin abnormalities or scalp skin diseases at the time of screening 2. Patients with secondary alopecia such as those associated with malnutrition, drugs, endocrine , iron deficiency anemia, or systemic lupus erythematosus; 3. Patients with alopecia areata, alopecia cicatrisata, or trichotillomania; 4. Having undergone hair transplantation or extension before screening, or persistent requirement to wear a wig sheath during study treatments; 5. Known allergy to the active ingredient of the investigational drug or any component of the excipients, or to any component of the tattoo liquid; 6. A history of depression, anxiety, personality disorder or other mental disorders; 7. A history of varicocele or infertility ; 8. A history of malignant tumor;
Healthy Volunteers: False
Sex: MALE
Minimum Age: 18 Years
Maximum Age: 41 Years
Study: NCT05135468
Study Brief:
Protocol Section: NCT05135468